Type to search

Closes ~$20 Million Series A Funding Round | Pharmtech Focus
Diseases, Fundraising, Industry News, Neurology
CraniUS Closes ~$20 Million Series A Funding Round
Alisa Thoren September 28, 2022

CraniUS LLC, an R&D company focused on building groundbreaking treatments for patients with chronic brain disease, today announced the closing of a $19.4 million Series A fundraising round. The Series A round, funded entirely by private investors, ...

chat_bubble0 Comment visibility150 Views
Covalab, Cimcure and Partners Receive €1.06M EUREKA Eurostars Grant to Develop New Combination Therapy for Glioblastoma | Pharmtech Focus
Fundraising, Industry News, Neurology, Partnerships
Covalab, Cimcure and Partners Receive €1.06M EUREKA Eurostars Grant to Develop New Combination Therapy for Glioblastoma
Alisa Thoren September 21, 2022

Covalab, a biotechnology company that specializes in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, today announces that together with CimCure, a Dutch biotech company focusing on the development of ...

chat_bubble0 Comment visibility186 Views
Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug | Pharmtech Focus
Clinical Trials, Diseases, Immunology, Industry News, Neurology, News, Partnerships
Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
Alisa Thoren September 16, 2022

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN ( NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to develop a companion diagnostic ...

chat_bubble0 Comment visibility245 Views
Pharmtech Focus report on the latest Pharmtech news, bringing you up to the minute stories and features to stay ahead. Industry professionals and decision makers turn to us to keep up with and shape their industry.
Contact

For Media, Press and Advertising Enquiries please use our contact form or email address:


Contact

Email

Advertainment Media Ltd.
Pantiles Chambers
85 High Street
Tunbridge Wells
TN1 1XP

Copyright © Advertainment Media All Rights Reserved